• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Screening system for chemicals attacking pre-mRNA splicing machinery in cells

Research Project

Project/Area Number 13670334
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hygiene
Research InstitutionKobe University Graduate School of medicine

Principal Investigator

NISHIO Hisahide  Kobe University Graduate School medicine Professor, 大学院・医学系研究科, 教授 (80189258)

Co-Investigator(Kenkyū-buntansha) MATSUO Masafumi  Kobe University Graduate School of medicine Professor, 大学院・医学系研究科, 教授 (10157266)
AYAKI Hitoshi  Kobe University Graduate School of medicine Associate Professor, 大学院・医学系研究科, 助教授 (80222701)
LIEE Jin  Kobe University Graduate School of medicine Lecturer, 大学院・医学系研究科, 講師 (20273766)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2002: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2001: ¥2,500,000 (Direct Cost: ¥2,500,000)
Keywordspre-mRNA / splicing / splicing enhancer sequences / the dsx gene / mini-gene / anti-SMN antibody / spinal muscular atrophy / cadmium / メッセンジャーRNA前駆体 / SMN蛋白 / 可変スプライシング
Research Abstract

It has been expected that some environmental chemicals attack the cellular splicing machinery to block the gene functions. Such chemicals, however, have never been reported so far. During our investigation of some inherited disorders with abnormal splicing pattern of the genes, we established splicing assay system with artificial pre-mRNA. In 2001, we constructed a mini-gene, of which transcripts were used as pre-mRNA. This mini-gene was a chimeric plasmid which consisted of T7 promoter, the third exon-the third intron-the 5' part of the fourth exon of the Drosophila melanogaster double sex gene (dsx) and splicing enhancer sequences (SES) selected from exons of the human dystrophin gene.
In 2002, we performed splicing assays using the mini-genes in the HeLa nuclear extract. High splicing efficiency was observed in the assays using the mini-genes with SESs from exons 19 and 26, When anti-SMN antibody was added in the HeLa nuclear extract, splicing reaction using the mini-gene with SES fr … More om exon 19 was blocked but splicing reaction using the mini-gene with SES from exon 26 was not blocked. The anti-SMN antibody is against the SMN protein, which is a product of the responsible gene for spinal muscular atrophy. when cadmium chloride (CdC12) solution was added in the HeLa nuclear extract, splicing reaction using the mini-gene with SES from exon 19 was blocked. The degree of splicing blockade was dependent on the CdC12 concentration.
These findings suggest that splicing efficiency is, at least partly, dependent on the SESs ; some chemical may affect splicing of some exons, but the same chemical may not affect splicing of the other exons. We can also expect that some chemical may affect splicing of some exons in the HeLa nuclear extract, but the same chemical may not affect splicing of the same exons in the non-HeLa nuclear extract. However, our preliminary study showed a new kind of cadmium toxicity affecting splicing machinery. In addition, the present study with anti-SMN antibody gives some clues to understanding of the pathogenesis of spinal muscular atrophy. Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Ito T: "One of three examined purine-rich sequences selected from dystrophin exones exhibits splicing enhancer activity"Acta Myologica.. 20. 151-153 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takeshima Y: "Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells front a Duchenne muscular dystrophy patient"Brain Dev.. 23. 788-790 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ito T: "Purine-rich exon sequences are not necessarily splicing enhancer sequence in the dystrophin gene"Kobe J.Med.Sci.. 47. 193-202 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 竹島泰弘: "アンチセンス・オリゴヌクレオチドを用いたエクソンスキッピング誘導による遺伝子治療"別冊実験医学. 175-182 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Harada Y: "Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy : three SMN2 copies fail to rescue some patients from the disease severity"J.Neurol.. 249. 1211-1219 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ito T.: "One of three examined purine-rich sequences selected from dystrophin exones exhibits splicing enhancer activity"Acta Myologica. 20. 151-153 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takeshima Y.: "Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient"Brain Dev.. 23. 788-790 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ito T.: "Purine-rich exon sequences are not necessarily splicing enhancer sequence in the dystrophin gene"Kobe J.Med.Sci.. 47. 193-202 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Harada Y.: "Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy : three SMN2 copies fail to rescue some patients from the disease severity"J. Neuro1. 249. 1211-1219 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ito.T, Takeshima Y, Nakamura H, Matsuo M.: "One of three examined purine-rich sequences selected from dystrophin exons exhibits splicing enhancer activity"Acta Myologic. 20巻. 151-153 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ito.T, Takeshima Y, Sakamoto H, Nakamura H, Matsuo M.: "Purine-rich exon sequences are not necessarily splicing enhancer sepquence in the dystrophin gene"Kobe. J. Med. Sci.. 47巻. 193-2002 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] 竹島泰弘, 松尾雅文: "アンチセンス・オリオヌクレオチドを用いたエクソンスキッピング誘導による遺伝子治療"別冊実験医学 ザ・プロトコールシリーズ 遺伝子の機能障害実験 簡単で確実な遺伝子機能解析からの遺伝子治療への応用まで. 175-182 (2001)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi